Repository logo
 

A single dividing cell population with imbalanced fate drives oesophageal tumour growth.

Accepted version
Peer-reviewed

Type

Article

Change log

Authors

Frede, Julia 
Nagy, Tibor 
Simons, Benjamin D 
Jones, Philip H 

Abstract

Understanding the cellular mechanisms of tumour growth is key for designing rational anticancer treatment. Here we used genetic lineage tracing to quantify cell behaviour during neoplastic transformation in a model of oesophageal carcinogenesis. We found that cell behaviour was convergent across premalignant tumours, which contained a single proliferating cell population. The rate of cell division was not significantly different in the lesions and the surrounding epithelium. However, dividing tumour cells had a uniform, small bias in cell fate so that, on average, slightly more dividing than non-dividing daughter cells were generated at each round of cell division. In invasive cancers induced by Kras(G12D) expression, dividing cell fate became more strongly biased towards producing dividing over non-dividing cells in a subset of clones. These observations argue that agents that restore the balance of cell fate may prove effective in checking tumour growth, whereas those targeting cycling cells may show little selectivity.

Description

Keywords

Animals, Cell Differentiation, Cell Division, Cell Lineage, Cell Proliferation, Cell Transformation, Neoplastic, Esophageal Mucosa, Esophageal Neoplasms, Humans, Mice, Transgenic, Mutation

Journal Title

Nat Cell Biol

Conference Name

Journal ISSN

1465-7392
1476-4679

Volume Title

18

Publisher

Springer Science and Business Media LLC
Sponsorship
Engineering and Physical Sciences Research Council (EP/F032773/1)
Wellcome Trust (098357/Z/12/Z)
Medical Research Council (MC_PC_12009)
Medical Research Council (MC_UU_12022/3)
Cancer Research UK (C609/A17257)
MRC (unknown)
Cancer Research UK (Grant ID: C609/A17257), Medical Research Council (Grant-in-Aid), DFG (Research Fellowship), Engineering and Physical Sciences Research Council (Critical Mass Grant), Wellcome Trust (Grant ID: 098357/Z/12/Z)